Loading…

Calcium, Phosphorus, Cardiovascular Events and All-cause Mortality in Hemodialysis Patients: A Single-center Retrospective Cohort Study to Reassess the Validity of the Japanese Society for Dialysis Therapy Guidelines

:  Mineral and bone disorders frequently cause cardiovascular complications and mortality in hemodialysis patients, but few observational studies of Japanese patients have investigated this matter. A retrospective cohort study of 99 patients (53 males, 46 females; mean age: 65 ± 12 year; 38% with di...

Full description

Saved in:
Bibliographic Details
Published in:Therapeutic apheresis and dialysis 2008-02, Vol.12 (1), p.42-48
Main Authors: Komaba, Hirotaka, Igaki, Naoya, Takashima, Mototsugu, Goto, Shunsuke, Yokota, Kazuki, Komada, Hisako, Takemoto, Toshiyuki, Kohno, Maki, Kadoguchi, Hiraku, Hirosue, Yoshiaki, Goto, Takeo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5259-7adab7353261efc397292e97c106dc3a2936f675e32748f566b7134aaea5cb623
cites cdi_FETCH-LOGICAL-c5259-7adab7353261efc397292e97c106dc3a2936f675e32748f566b7134aaea5cb623
container_end_page 48
container_issue 1
container_start_page 42
container_title Therapeutic apheresis and dialysis
container_volume 12
creator Komaba, Hirotaka
Igaki, Naoya
Takashima, Mototsugu
Goto, Shunsuke
Yokota, Kazuki
Komada, Hisako
Takemoto, Toshiyuki
Kohno, Maki
Kadoguchi, Hiraku
Hirosue, Yoshiaki
Goto, Takeo
description :  Mineral and bone disorders frequently cause cardiovascular complications and mortality in hemodialysis patients, but few observational studies of Japanese patients have investigated this matter. A retrospective cohort study of 99 patients (53 males, 46 females; mean age: 65 ± 12 year; 38% with diabetes mellitus) on maintenance hemodialysis in our dialysis center was conducted. Mean serum Ca, P and intact parathyroid hormone (iPTH) levels were 9.2 ± 0.9 mg/dL, 6.1 ± 1.7 mg/dL, and 233 ± 333 pg/mL, respectively. The cutoff values for each of these three parameter were defined according to the target ranges recommended by the Japanese Society for Dialysis Therapy (JSDT) guidelines (Ca: 8.4–10.0 mg/dL; P: 3.5–6.0 mg/dL; iPTH: 60–180 pg/mL). During a 45‐month follow up, patients with all parameters outside the target ranges showed the highest incidence of cardiovascular events and all‐cause deaths (16.6 and 29.2 per 1000 person‐years, respectively). The relative risks of cardiovascular events and all‐cause deaths were analyzed by multivariate Cox regression models. The hazard ratio (HR) for cardiovascular events was significantly lower for patients who achieved serum Ca and P objectives compared with others (HR: 2.12; 95% CI: 1.04–4.34; P 
doi_str_mv 10.1111/j.1744-9987.2007.00539.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70279079</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20458138</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5259-7adab7353261efc397292e97c106dc3a2936f675e32748f566b7134aaea5cb623</originalsourceid><addsrcrecordid>eNqNUc2O0zAQjhCIXRZeAfnEadN17CROEJcStl2gQEULSFws15lQd9262E63eVMeB2dbyhF88Yzn-xn5iyKU4EESztVqkLA0jcuyYAOCMRtgnNFysH8QnZ8GD081K8-iJ86tMCYkpfRxdJYUJGNFkpxHvyqhpWrXl2i6NG67NLZ1l6gStlZmJ5xstbDoegcb75DY1GiodSxF6wB9MNYLrXyH1AbdwNrUSujOKYemwque8BIN0UxtfmiIZejBos_gbXAB6dUOUGWCnUcz39Yd8iZMhXPgHPJLQF-Ddt2rm-a-fye2YgPBd2akgvDeGIve_LGcL8GKbYfGrapBqwB8Gj1qhHbw7HhfRF9G1_PqJp58Gr-thpNYZiQrYyZqsWA0oyRPoJG0ZKQkUDKZ4LyWVJCS5k3OMqCEpUWT5fmCJTQVAkQmFzmhF9GLg-7Wmp8tOM_XyknQOmxrWscZJqzErPwnkOA0KxJaBGBxAMrwV85Cw7dWrYXteIJ5Hz9f8T5Z3qfM-_j5ffx8H6jPjx7tYg31X-Ix7wB4dQDcKQ3dfwvz-XAaikCPD3TlPOxPdGFvec4oy_i3j2M-IaNq-vr9iH-nvwGp4dHr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20458138</pqid></control><display><type>article</type><title>Calcium, Phosphorus, Cardiovascular Events and All-cause Mortality in Hemodialysis Patients: A Single-center Retrospective Cohort Study to Reassess the Validity of the Japanese Society for Dialysis Therapy Guidelines</title><source>Wiley</source><creator>Komaba, Hirotaka ; Igaki, Naoya ; Takashima, Mototsugu ; Goto, Shunsuke ; Yokota, Kazuki ; Komada, Hisako ; Takemoto, Toshiyuki ; Kohno, Maki ; Kadoguchi, Hiraku ; Hirosue, Yoshiaki ; Goto, Takeo</creator><creatorcontrib>Komaba, Hirotaka ; Igaki, Naoya ; Takashima, Mototsugu ; Goto, Shunsuke ; Yokota, Kazuki ; Komada, Hisako ; Takemoto, Toshiyuki ; Kohno, Maki ; Kadoguchi, Hiraku ; Hirosue, Yoshiaki ; Goto, Takeo</creatorcontrib><description>:  Mineral and bone disorders frequently cause cardiovascular complications and mortality in hemodialysis patients, but few observational studies of Japanese patients have investigated this matter. A retrospective cohort study of 99 patients (53 males, 46 females; mean age: 65 ± 12 year; 38% with diabetes mellitus) on maintenance hemodialysis in our dialysis center was conducted. Mean serum Ca, P and intact parathyroid hormone (iPTH) levels were 9.2 ± 0.9 mg/dL, 6.1 ± 1.7 mg/dL, and 233 ± 333 pg/mL, respectively. The cutoff values for each of these three parameter were defined according to the target ranges recommended by the Japanese Society for Dialysis Therapy (JSDT) guidelines (Ca: 8.4–10.0 mg/dL; P: 3.5–6.0 mg/dL; iPTH: 60–180 pg/mL). During a 45‐month follow up, patients with all parameters outside the target ranges showed the highest incidence of cardiovascular events and all‐cause deaths (16.6 and 29.2 per 1000 person‐years, respectively). The relative risks of cardiovascular events and all‐cause deaths were analyzed by multivariate Cox regression models. The hazard ratio (HR) for cardiovascular events was significantly lower for patients who achieved serum Ca and P objectives compared with others (HR: 2.12; 95% CI: 1.04–4.34; P &lt; 0.05), and similar differences were observed for all‐cause deaths (HR: 3.10; 95% CI: 1.13–8.53; P &lt; 0.05). However, the relationship between iPTH levels and each of the endpoints was less pronounced. The results of this study provide support for the JSDT guidelines, which give priority to the control of serum Ca and P levels over the control of parathyroid function.</description><identifier>ISSN: 1744-9979</identifier><identifier>EISSN: 1744-9987</identifier><identifier>DOI: 10.1111/j.1744-9987.2007.00539.x</identifier><identifier>PMID: 18257811</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Publishing Asia</publisher><subject>Aged ; Asian Continental Ancestry Group ; Calcium ; Calcium - blood ; Cardiovascular Diseases - epidemiology ; Cardiovascular Diseases - etiology ; Cardiovascular Diseases - prevention &amp; control ; Cardiovascular event ; Cohort Studies ; Female ; Follow-Up Studies ; Hemodialysis patient ; Humans ; Incidence ; Japan ; JSDT guidelines ; Male ; Middle Aged ; Parathyroid Hormone - blood ; Phosphorus ; Phosphorus - blood ; Practice Guidelines as Topic ; Proportional Hazards Models ; Renal Dialysis - mortality ; Retrospective Studies ; Secondary hyperparathyroidism</subject><ispartof>Therapeutic apheresis and dialysis, 2008-02, Vol.12 (1), p.42-48</ispartof><rights>2008 The Authors</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5259-7adab7353261efc397292e97c106dc3a2936f675e32748f566b7134aaea5cb623</citedby><cites>FETCH-LOGICAL-c5259-7adab7353261efc397292e97c106dc3a2936f675e32748f566b7134aaea5cb623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18257811$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Komaba, Hirotaka</creatorcontrib><creatorcontrib>Igaki, Naoya</creatorcontrib><creatorcontrib>Takashima, Mototsugu</creatorcontrib><creatorcontrib>Goto, Shunsuke</creatorcontrib><creatorcontrib>Yokota, Kazuki</creatorcontrib><creatorcontrib>Komada, Hisako</creatorcontrib><creatorcontrib>Takemoto, Toshiyuki</creatorcontrib><creatorcontrib>Kohno, Maki</creatorcontrib><creatorcontrib>Kadoguchi, Hiraku</creatorcontrib><creatorcontrib>Hirosue, Yoshiaki</creatorcontrib><creatorcontrib>Goto, Takeo</creatorcontrib><title>Calcium, Phosphorus, Cardiovascular Events and All-cause Mortality in Hemodialysis Patients: A Single-center Retrospective Cohort Study to Reassess the Validity of the Japanese Society for Dialysis Therapy Guidelines</title><title>Therapeutic apheresis and dialysis</title><addtitle>Ther Apher Dial</addtitle><description>:  Mineral and bone disorders frequently cause cardiovascular complications and mortality in hemodialysis patients, but few observational studies of Japanese patients have investigated this matter. A retrospective cohort study of 99 patients (53 males, 46 females; mean age: 65 ± 12 year; 38% with diabetes mellitus) on maintenance hemodialysis in our dialysis center was conducted. Mean serum Ca, P and intact parathyroid hormone (iPTH) levels were 9.2 ± 0.9 mg/dL, 6.1 ± 1.7 mg/dL, and 233 ± 333 pg/mL, respectively. The cutoff values for each of these three parameter were defined according to the target ranges recommended by the Japanese Society for Dialysis Therapy (JSDT) guidelines (Ca: 8.4–10.0 mg/dL; P: 3.5–6.0 mg/dL; iPTH: 60–180 pg/mL). During a 45‐month follow up, patients with all parameters outside the target ranges showed the highest incidence of cardiovascular events and all‐cause deaths (16.6 and 29.2 per 1000 person‐years, respectively). The relative risks of cardiovascular events and all‐cause deaths were analyzed by multivariate Cox regression models. The hazard ratio (HR) for cardiovascular events was significantly lower for patients who achieved serum Ca and P objectives compared with others (HR: 2.12; 95% CI: 1.04–4.34; P &lt; 0.05), and similar differences were observed for all‐cause deaths (HR: 3.10; 95% CI: 1.13–8.53; P &lt; 0.05). However, the relationship between iPTH levels and each of the endpoints was less pronounced. The results of this study provide support for the JSDT guidelines, which give priority to the control of serum Ca and P levels over the control of parathyroid function.</description><subject>Aged</subject><subject>Asian Continental Ancestry Group</subject><subject>Calcium</subject><subject>Calcium - blood</subject><subject>Cardiovascular Diseases - epidemiology</subject><subject>Cardiovascular Diseases - etiology</subject><subject>Cardiovascular Diseases - prevention &amp; control</subject><subject>Cardiovascular event</subject><subject>Cohort Studies</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Hemodialysis patient</subject><subject>Humans</subject><subject>Incidence</subject><subject>Japan</subject><subject>JSDT guidelines</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Parathyroid Hormone - blood</subject><subject>Phosphorus</subject><subject>Phosphorus - blood</subject><subject>Practice Guidelines as Topic</subject><subject>Proportional Hazards Models</subject><subject>Renal Dialysis - mortality</subject><subject>Retrospective Studies</subject><subject>Secondary hyperparathyroidism</subject><issn>1744-9979</issn><issn>1744-9987</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqNUc2O0zAQjhCIXRZeAfnEadN17CROEJcStl2gQEULSFws15lQd9262E63eVMeB2dbyhF88Yzn-xn5iyKU4EESztVqkLA0jcuyYAOCMRtgnNFysH8QnZ8GD081K8-iJ86tMCYkpfRxdJYUJGNFkpxHvyqhpWrXl2i6NG67NLZ1l6gStlZmJ5xstbDoegcb75DY1GiodSxF6wB9MNYLrXyH1AbdwNrUSujOKYemwque8BIN0UxtfmiIZejBos_gbXAB6dUOUGWCnUcz39Yd8iZMhXPgHPJLQF-Ddt2rm-a-fye2YgPBd2akgvDeGIve_LGcL8GKbYfGrapBqwB8Gj1qhHbw7HhfRF9G1_PqJp58Gr-thpNYZiQrYyZqsWA0oyRPoJG0ZKQkUDKZ4LyWVJCS5k3OMqCEpUWT5fmCJTQVAkQmFzmhF9GLg-7Wmp8tOM_XyknQOmxrWscZJqzErPwnkOA0KxJaBGBxAMrwV85Cw7dWrYXteIJ5Hz9f8T5Z3qfM-_j5ffx8H6jPjx7tYg31X-Ix7wB4dQDcKQ3dfwvz-XAaikCPD3TlPOxPdGFvec4oy_i3j2M-IaNq-vr9iH-nvwGp4dHr</recordid><startdate>200802</startdate><enddate>200802</enddate><creator>Komaba, Hirotaka</creator><creator>Igaki, Naoya</creator><creator>Takashima, Mototsugu</creator><creator>Goto, Shunsuke</creator><creator>Yokota, Kazuki</creator><creator>Komada, Hisako</creator><creator>Takemoto, Toshiyuki</creator><creator>Kohno, Maki</creator><creator>Kadoguchi, Hiraku</creator><creator>Hirosue, Yoshiaki</creator><creator>Goto, Takeo</creator><general>Blackwell Publishing Asia</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7X8</scope></search><sort><creationdate>200802</creationdate><title>Calcium, Phosphorus, Cardiovascular Events and All-cause Mortality in Hemodialysis Patients: A Single-center Retrospective Cohort Study to Reassess the Validity of the Japanese Society for Dialysis Therapy Guidelines</title><author>Komaba, Hirotaka ; Igaki, Naoya ; Takashima, Mototsugu ; Goto, Shunsuke ; Yokota, Kazuki ; Komada, Hisako ; Takemoto, Toshiyuki ; Kohno, Maki ; Kadoguchi, Hiraku ; Hirosue, Yoshiaki ; Goto, Takeo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5259-7adab7353261efc397292e97c106dc3a2936f675e32748f566b7134aaea5cb623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Aged</topic><topic>Asian Continental Ancestry Group</topic><topic>Calcium</topic><topic>Calcium - blood</topic><topic>Cardiovascular Diseases - epidemiology</topic><topic>Cardiovascular Diseases - etiology</topic><topic>Cardiovascular Diseases - prevention &amp; control</topic><topic>Cardiovascular event</topic><topic>Cohort Studies</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Hemodialysis patient</topic><topic>Humans</topic><topic>Incidence</topic><topic>Japan</topic><topic>JSDT guidelines</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Parathyroid Hormone - blood</topic><topic>Phosphorus</topic><topic>Phosphorus - blood</topic><topic>Practice Guidelines as Topic</topic><topic>Proportional Hazards Models</topic><topic>Renal Dialysis - mortality</topic><topic>Retrospective Studies</topic><topic>Secondary hyperparathyroidism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Komaba, Hirotaka</creatorcontrib><creatorcontrib>Igaki, Naoya</creatorcontrib><creatorcontrib>Takashima, Mototsugu</creatorcontrib><creatorcontrib>Goto, Shunsuke</creatorcontrib><creatorcontrib>Yokota, Kazuki</creatorcontrib><creatorcontrib>Komada, Hisako</creatorcontrib><creatorcontrib>Takemoto, Toshiyuki</creatorcontrib><creatorcontrib>Kohno, Maki</creatorcontrib><creatorcontrib>Kadoguchi, Hiraku</creatorcontrib><creatorcontrib>Hirosue, Yoshiaki</creatorcontrib><creatorcontrib>Goto, Takeo</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Therapeutic apheresis and dialysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Komaba, Hirotaka</au><au>Igaki, Naoya</au><au>Takashima, Mototsugu</au><au>Goto, Shunsuke</au><au>Yokota, Kazuki</au><au>Komada, Hisako</au><au>Takemoto, Toshiyuki</au><au>Kohno, Maki</au><au>Kadoguchi, Hiraku</au><au>Hirosue, Yoshiaki</au><au>Goto, Takeo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Calcium, Phosphorus, Cardiovascular Events and All-cause Mortality in Hemodialysis Patients: A Single-center Retrospective Cohort Study to Reassess the Validity of the Japanese Society for Dialysis Therapy Guidelines</atitle><jtitle>Therapeutic apheresis and dialysis</jtitle><addtitle>Ther Apher Dial</addtitle><date>2008-02</date><risdate>2008</risdate><volume>12</volume><issue>1</issue><spage>42</spage><epage>48</epage><pages>42-48</pages><issn>1744-9979</issn><eissn>1744-9987</eissn><abstract>:  Mineral and bone disorders frequently cause cardiovascular complications and mortality in hemodialysis patients, but few observational studies of Japanese patients have investigated this matter. A retrospective cohort study of 99 patients (53 males, 46 females; mean age: 65 ± 12 year; 38% with diabetes mellitus) on maintenance hemodialysis in our dialysis center was conducted. Mean serum Ca, P and intact parathyroid hormone (iPTH) levels were 9.2 ± 0.9 mg/dL, 6.1 ± 1.7 mg/dL, and 233 ± 333 pg/mL, respectively. The cutoff values for each of these three parameter were defined according to the target ranges recommended by the Japanese Society for Dialysis Therapy (JSDT) guidelines (Ca: 8.4–10.0 mg/dL; P: 3.5–6.0 mg/dL; iPTH: 60–180 pg/mL). During a 45‐month follow up, patients with all parameters outside the target ranges showed the highest incidence of cardiovascular events and all‐cause deaths (16.6 and 29.2 per 1000 person‐years, respectively). The relative risks of cardiovascular events and all‐cause deaths were analyzed by multivariate Cox regression models. The hazard ratio (HR) for cardiovascular events was significantly lower for patients who achieved serum Ca and P objectives compared with others (HR: 2.12; 95% CI: 1.04–4.34; P &lt; 0.05), and similar differences were observed for all‐cause deaths (HR: 3.10; 95% CI: 1.13–8.53; P &lt; 0.05). However, the relationship between iPTH levels and each of the endpoints was less pronounced. The results of this study provide support for the JSDT guidelines, which give priority to the control of serum Ca and P levels over the control of parathyroid function.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Publishing Asia</pub><pmid>18257811</pmid><doi>10.1111/j.1744-9987.2007.00539.x</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1744-9979
ispartof Therapeutic apheresis and dialysis, 2008-02, Vol.12 (1), p.42-48
issn 1744-9979
1744-9987
language eng
recordid cdi_proquest_miscellaneous_70279079
source Wiley
subjects Aged
Asian Continental Ancestry Group
Calcium
Calcium - blood
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - etiology
Cardiovascular Diseases - prevention & control
Cardiovascular event
Cohort Studies
Female
Follow-Up Studies
Hemodialysis patient
Humans
Incidence
Japan
JSDT guidelines
Male
Middle Aged
Parathyroid Hormone - blood
Phosphorus
Phosphorus - blood
Practice Guidelines as Topic
Proportional Hazards Models
Renal Dialysis - mortality
Retrospective Studies
Secondary hyperparathyroidism
title Calcium, Phosphorus, Cardiovascular Events and All-cause Mortality in Hemodialysis Patients: A Single-center Retrospective Cohort Study to Reassess the Validity of the Japanese Society for Dialysis Therapy Guidelines
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T20%3A20%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Calcium,%20Phosphorus,%20Cardiovascular%20Events%20and%20All-cause%20Mortality%20in%20Hemodialysis%20Patients:%20A%20Single-center%20Retrospective%20Cohort%20Study%20to%20Reassess%20the%20Validity%20of%20the%20Japanese%20Society%20for%20Dialysis%20Therapy%20Guidelines&rft.jtitle=Therapeutic%20apheresis%20and%20dialysis&rft.au=Komaba,%20Hirotaka&rft.date=2008-02&rft.volume=12&rft.issue=1&rft.spage=42&rft.epage=48&rft.pages=42-48&rft.issn=1744-9979&rft.eissn=1744-9987&rft_id=info:doi/10.1111/j.1744-9987.2007.00539.x&rft_dat=%3Cproquest_cross%3E20458138%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5259-7adab7353261efc397292e97c106dc3a2936f675e32748f566b7134aaea5cb623%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20458138&rft_id=info:pmid/18257811&rfr_iscdi=true